These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8179595)

  • 1. PKC activity in rat C6 glioma cells: changes associated with cell cycle and simvastatin treatment.
    Soma MR; Baetta R; Bergamaschi S; De Renzis MR; Davegna C; Battaini F; Fumagalli R; Govoni S
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1143-9. PubMed ID: 8179595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin.
    Soma MR; Baetta R; De Renzis MR; Mazzini G; Davegna C; Magrassi L; Butti G; Pezzotta S; Paoletti R; Fumagalli R
    Cancer Res; 1995 Feb; 55(3):597-602. PubMed ID: 7834630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory effect of simvastatin on growth in malignant gliomas--with special reference to its local application with fibrin glue spray in vivo.
    Murakami M; Goto T; Saito Y; Goto S; Kochi M; Ushio Y
    Int J Oncol; 2001 Sep; 19(3):525-31. PubMed ID: 11494031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of HMG-CoA reductase inhibitors on growth and differentiation of cultured rat skeletal muscle cells.
    Veerkamp JH; Smit JW; Benders AA; Oosterhof A
    Biochim Biophys Acta; 1996 Apr; 1315(3):217-22. PubMed ID: 8611662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17 beta-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases activation.
    Bonapace IM; Addeo R; Altucci L; Cicatiello L; Bifulco M; Laezza C; Salzano S; Sica V; Bresciani F; Weisz A
    Oncogene; 1996 Feb; 12(4):753-63. PubMed ID: 8632897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W; Infante J; Wang SR; Infante R
    Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin and intracellular pH regulation by the Na+/H+ antiport of SV40-virus-transformed human MRC5 fibroblasts.
    Davies JE; Ng LL
    Clin Sci (Lond); 1993 Jun; 84(6):633-43. PubMed ID: 8392920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of human breast cancer MCF-7 cells with estrogen prevents cell cycle arrest by HMG-CoA reductase inhibitors.
    Addeo R; Altucci L; Battista T; Bonapace IM; Cancemi M; Cicatiello L; Germano D; Pacilio C; Salzano S; Bresciani F; Weisz A
    Biochem Biophys Res Commun; 1996 Mar; 220(3):864-70. PubMed ID: 8607857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types.
    Nègre-Aminou P; van Vliet AK; van Erck M; van Thiel GC; van Leeuwen RE; Cohen LH
    Biochim Biophys Acta; 1997 Apr; 1345(3):259-68. PubMed ID: 9150246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution pattern of acridine orange chromatin interaction products in rat glioma C6 cells at different phases of the cell cycle.
    Hara H; Moriki T; Hiroi M; Watanabe S; Yamane T; Lehmann R
    Pathol Res Pract; 1990 Feb; 186(1):110-6. PubMed ID: 1690412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin, an inhibitor of cholesterol biosynthesis, shows a synergistic effect with N,N'-bis(2-chloroethyl)-N-nitrosourea and beta-interferon on human glioma cells.
    Soma MR; Pagliarini P; Butti G; Paoletti R; Paoletti P; Fumagalli R
    Cancer Res; 1992 Aug; 52(16):4348-55. PubMed ID: 1643632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase.
    Rao S; Porter DC; Chen X; Herliczek T; Lowe M; Keyomarsi K
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7797-802. PubMed ID: 10393901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin inhibits the cellular signaling and proliferative action of arginine vasopressin in cultured rat glomerular mesangial cells.
    Ishikawa S; Kawasumi M; Saito T
    Endocrinology; 1995 May; 136(5):1954-61. PubMed ID: 7720643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical elevation of Ki-67 labeling with protein kinase inhibition in malignant gliomas.
    Couldwell WT; Weiss MH; Law RE; Hinton DR
    J Neurosurg; 1995 Mar; 82(3):461-8. PubMed ID: 7861225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway.
    Zhong WB; Hsu SP; Ho PY; Liang YC; Chang TC; Lee WS
    Biochem Pharmacol; 2011 Dec; 82(11):1663-72. PubMed ID: 21907187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
    Choi JW; Jung SE
    J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of Simvastatin-Induced Inhibition of Tendon Cell Proliferation and Cell Cycle Progression by Geranylgeranyl Pyrophosphate.
    Tsai WC; Yu TY; Lin LP; Cheng ML; Chen CL; Pang JH
    Toxicol Sci; 2016 Feb; 149(2):326-34. PubMed ID: 26577051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro.
    Couldwell WT; Uhm JH; Antel JP; Yong VW
    Neurosurgery; 1991 Dec; 29(6):880-6; discussion 886-7. PubMed ID: 1758601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle-specific growth inhibition of human breast cancer cells induced by metabolic inhibitors.
    Larsson O
    Glycobiology; 1993 Oct; 3(5):475-9. PubMed ID: 8286860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.